Papers
31
Total Citations
727
H-Index
16
About
Qingquan Luo is a leading thoracic surgeon and researcher whose work has significantly advanced the field of minimally invasive thoracic surgery, with particular expertise in robotic-assisted surgical techniques for lung cancer and thoracic oncology. His research systematically compares robotic-assisted thoracic surgery (RATS) against conventional video-assisted thoracoscopic surgery (VATS) and open thoracotomy across a range of clinical contexts — from early-stage lung cancer to locally advanced non-small cell lung cancer (NSCLC) and thymomas. Luo's most cited work, including a 2019 comparison of robotic versus VATS lobectomy for stage IIB–IIIA NSCLC (74 citations) and a 2017 multi-approach thymoma study (63 citations), has helped establish evidence-based guidance for surgical decision-making in challenging oncologic cases. Notably, his randomized controlled trials evaluating RATS in clinical N2-stage NSCLC patients represent some of the most rigorous evidence in this domain, demonstrating comparable long-term survival with reduced perioperative complications. Luo has also contributed to surgical robotics innovation, co-authoring reviews on emerging robotic platforms and the development of the modular SHURUI continuum surgical system (57 citations). Collectively, his body of work, spanning over 500 citations, positions him as a pivotal figure in shaping the future of minimally invasive thoracic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10